- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04220502
Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae
May 3, 2022 updated by: Steven D Daveluy, Wayne State University
Depilatory Cream's Affect on the Occurrence of Pseudofolliculitis Barbae
Comparing the amount of papules, macules, pustules, and irritation caused by pseudofolluculitis barbae in subjects using depilatory cream versus traditional shaving methods.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Comparing an experimental group that will remove facial hair with magic shave powder gold, and a control group that will continue using traditional shaving methods.
Both the subject and a physician will make observations to determine the efficacy of depilatory creams in reducing pseudofolliculits barbae.
Study Type
Interventional
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Dearborn, Michigan, United States, 48124
- Wayne State University Physician Group Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- PFB patient
Exclusion Criteria:
- Failed sensitivity testing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Magic Shave Powder Gold
This group will receive magic shaving powder gold and instructions on how to apply it.
They will keep a log for their facial hair removal
|
Depilatory Cream for facial hair removal
Other Names:
|
Other: Traditional Methods
This group will continue using traditional razors with the standard of care directions to shave.
They will keep a log of their facial hair removal
|
Continued facial hair removal using traditional razors
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Investigator Global Assessment
Time Frame: 12 weeks
|
Difference in the investigator assessment of lesions and irritation at baseline and 12 weeks, measured by investigator.
The scale title is Investigator Global Assessment, the minimum value is 0, the maximum is 5. Higher scores mean worse outcome.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Global Assessment
Time Frame: 12 weeks
|
Difference in the investigator assessment of disease symptoms at baseline and 12 weeks, measured by patient.
The scale title is Patient Global Assessment, the minimum value is 0, the maximum is 5. Higher scores mean worse outcome.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Steven Daveluy, MD, Wayne State University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Daniel A, Gustafson CJ, Zupkosky PJ, Candido A, Kemp HR, Russell G, McMichael A. Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae. J Drugs Dermatol. 2013 Apr;12(4):410-8.
- Kindred C, Oresajo CO, Yatskayer M, Halder RM. Comparative evaluation of men's depilatory composition versus razor in black men. Cutis. 2011 Aug;88(2):98-103.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2020
Primary Completion (Actual)
May 3, 2022
Study Completion (Actual)
May 3, 2022
Study Registration Dates
First Submitted
January 3, 2020
First Submitted That Met QC Criteria
January 3, 2020
First Posted (Actual)
January 7, 2020
Study Record Updates
Last Update Posted (Actual)
May 9, 2022
Last Update Submitted That Met QC Criteria
May 3, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WayneMed
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pseudofolliculitis Barbae
-
Wake Forest University Health SciencesProcter and GambleActive, not recruitingPseudofolliculitis BarbaeUnited States
-
Walter Reed National Military Medical CenterTerminatedPseudofolliculitis BarbaeUnited States
-
Wake Forest University Health SciencesCompleted
-
Hordinsky, Maria K., MDCompletedPseudofolliculitis BarbaeUnited States
-
United States Naval Medical Center, San DiegoCompletedPseudofolliculitis BarbaeUnited States
-
Candela CorporationCompletedOnychomycosis | Acne | Wrinkle | Pigmented Lesions | Pseudofolliculitis Barbae | Unwanted Hair | Vascular LesionUnited States
-
Cynosure, Inc.CompletedHair Removal | Pseudo Folliculitis Barbae | Benign Vascular Lesion | Pigmented LesionsUnited States
-
National institute of SiddhaCompletedTinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are StudiedIndia
-
Faculty Hospital Kralovske VinohradyCompletedInfections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditionsCzechia
Clinical Trials on Magic Shave Powder Gold
-
AIDP, Inc.KGK Science Inc.CompletedHealthy | Functional ConstipationCanada
-
University of UtahActive, not recruitingSleep | Body Weight Changes | Recovery | Athletic PerformanceUnited States
-
Naturex SABiofortis Mérieux NutriSciencesCompleted